Kristen Harrington-Smith
Directeur/Membre du Conseil chez EFFECTOR THERAPEUTICS, INC.
Fortune : 733 000 $ au 31/01/2024
Postes actifs de Kristen Harrington-Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/02/2022 | - |
| Independent Dir/Board Member | 15/02/2022 | - | |
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 17/11/2022 | - |
Historique de carrière de Kristen Harrington-Smith
Anciens postes connus de Kristen Harrington-Smith
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 16/11/2021 | 16/11/2022 |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 01/03/2020 | 01/11/2021 |
Formation de Kristen Harrington-Smith
| Williams College | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Allemagne | 2 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Bourse
- Insiders
- Kristen Harrington-Smith
- Expérience
